Our Approved Funding Grants and Research Projects

     Evaluation of accessibility and variety of medications available to Shiraz community (households) in Shiraz1395: a Population-Based Study. (2016-2018)

 

       Essential Hypoglycemic (Anti Diabetes) medicine list compilation in Iran health system (National Grant from FDA of Iran )

 

     Essential cardiovascular medicine list compilation in Iran health system (National Grant from FDA of Iran )

  

     Measuring medicine prices, availability, affordability and price components. (National Grant from FDA of Iran) 

 

     Evaluation and Preparing Guideline of patients care in pharmacy, at Shiraz community Pharmacy store

 

      Effect of octereotide in control of nonvariceal upper GI bleeding: randomized control trial: randomized doubleblind controlled trial. Completed (2016-2018)

 

   The therapeutic effect of Midodrine in patients with refractory gastro esophageal reflux disease: a randomized double-blind clinical trial. Completed (2015-2017)

 

      Determination of affordable medicines and those facing catastrophic drug cost and the resulting poverty, In collaboration with the Iran Food and Drug Administration (In process)

 

     Essential Diabetics medicine list compilation in Iran health system, in collaboration with the Iran Food and Drug Administration (In process)

  

  Essential cardiovascular medicine list compilation in Iran health system, in collaboration with the Iran Food and Drug Administration (In process)

 

 
Health policy Research Center
 71348-45794 :Postal code
Tel & Fax: + 98 71 3230 9615
Email: health.policy.research@gmail.com
Telegram: @HealthPolicyShiraz